The present study investigated the
mRNA expression level of
ubiquitin c-terminal hydrolase (UCH)-L1 and -L3 in
breast cancer tissue and aimed to elucidate its association with
tumor characteristics and patient prognosis. UCH-L1 and UCH-L3
mRNA levels in invasive
breast cancer (n = 100) were determined by a real-time polymerase chain reaction (PCR) assay and their relationship with various clinicopathological characteristics of
breast tumors as well as patient prognosis were studied. UCH-L3
mRNA level was significantly upregulated in
breast cancer tissue compared to adjacent normal breast tissue (P < 0.005), and UHC-L1
mRNA level also showed a non-significant increase in
tumor tissue compared to adjacent normal breast tissue. Both UCH-L1 and UCH-L3
mRNA levels were significantly higher in high histological grade
tumors than in low histological grade
tumors (P < 0.001 and P < 0.005, respectively). High UCH-L1
mRNA level was significantly associated with negative
estrogen receptor status (P < 0.05) and negative
progesterone receptor status (P < 0.05). Patients with both UCH-L1 and UCH-L3
mRNA high
tumors showed a significantly poorer prognosis than those in the UCH-L1 or UCH-L3
mRNA low group (P < 0.005). These observations that UCH-L3
mRNA level is upregulated in
breast cancer tissue, and
breast tumors with both UCH-L1 and UCH-L3
mRNA high expression are associated with a poor prognosis, suggest the possible involvement of UCH-L1 and UCH-L3 in the pathogenesis and progression of
breast cancer.